ArticleHeliyon2023

Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers.

Giulio Fracasso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.